+1 347 708 0418
The Urological Cancer Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Urological Cancer Therapeutics Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Urological Cancer Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Urological Cancer Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
Market segment by Application can be divided into
Hospital
Medical Research Laboratory
Others
The key market players for global Urological Cancer Therapeutics Drugs market are listed below:
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Urological Cancer Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Urological Cancer Therapeutics Drugs, with price, sales, revenue and global market share of Urological Cancer Therapeutics Drugs from 2019 to 2021.
Chapter 3, the Urological Cancer Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urological Cancer Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Urological Cancer Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Urological Cancer Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Urological Cancer Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market Analysis by Application
1.3.1 Overview: Global Urological Cancer Therapeutics Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Global Urological Cancer Therapeutics Drugs Market Size & Forecast
1.4.1 Global Urological Cancer Therapeutics Drugs Sales in Value (2016-2026))
1.4.2 Global Urological Cancer Therapeutics Drugs Sales in Volume (2016-2026)
1.4.3 Global Urological Cancer Therapeutics Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Urological Cancer Therapeutics Drugs Production Capacity Analysis
1.5.1 Global Urological Cancer Therapeutics Drugs Total Production Capacity (2016-2026)
1.5.2 Global Urological Cancer Therapeutics Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Urological Cancer Therapeutics Drugs Market Drivers
1.6.2 Urological Cancer Therapeutics Drugs Market Restraints
1.6.3 Urological Cancer Therapeutics Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Urological Cancer Therapeutics Drugs Product and Services
2.1.4 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Urological Cancer Therapeutics Drugs Product and Services
2.2.4 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Product and Services
2.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Product and Services
2.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Astellas
2.5.1 Astellas Details
2.5.2 Astellas Major Business
2.5.3 Astellas Urological Cancer Therapeutics Drugs Product and Services
2.5.4 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product and Services
2.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Abbott Laboratories
2.7.1 Abbott Laboratories Details
2.7.2 Abbott Laboratories Major Business
2.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Product and Services
2.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Celgene Corporation
2.8.1 Celgene Corporation Details
2.8.2 Celgene Corporation Major Business
2.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Product and Services
2.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Dendreon Corporation
2.9.1 Dendreon Corporation Details
2.9.2 Dendreon Corporation Major Business
2.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Product and Services
2.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Ferring Pharmaceuticals
2.10.1 Ferring Pharmaceuticals Details
2.10.2 Ferring Pharmaceuticals Major Business
2.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product and Services
2.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline plc
2.11.1 GlaxoSmithKline plc Details
2.11.2 GlaxoSmithKline plc Major Business
2.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product and Services
2.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Indevus Pharmaceuticals Inc
2.12.1 Indevus Pharmaceuticals Inc Details
2.12.2 Indevus Pharmaceuticals Inc Major Business
2.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product and Services
2.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Ipsen
2.13.1 Ipsen Details
2.13.2 Ipsen Major Business
2.13.3 Ipsen Urological Cancer Therapeutics Drugs Product and Services
2.13.4 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Roche Healthcare
2.14.1 Roche Healthcare Details
2.14.2 Roche Healthcare Major Business
2.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Product and Services
2.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Sanofi S.A.
2.15.1 Sanofi S.A. Details
2.15.2 Sanofi S.A. Major Business
2.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Product and Services
2.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Urological Cancer Therapeutics Drugs Sales by Manufacturer
3.1 Global Urological Cancer Therapeutics Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Urological Cancer Therapeutics Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Urological Cancer Therapeutics Drugs Manufacturer Market Share
3.4.2 Top 6 Urological Cancer Therapeutics Drugs Manufacturer Market Share
3.5 Global Urological Cancer Therapeutics Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Urological Cancer Therapeutics Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Urological Cancer Therapeutics Drugs Market Size by Region
4.1.1 Global Urological Cancer Therapeutics Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Urological Cancer Therapeutics Drugs Revenue by Region (2016-2026)
4.2 North America Urological Cancer Therapeutics Drugs Revenue (2016-2026)
4.3 Europe Urological Cancer Therapeutics Drugs Revenue (2016-2026)
4.4 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (2016-2026)
4.5 South America Urological Cancer Therapeutics Drugs Revenue (2016-2026)
4.6 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Urological Cancer Therapeutics Drugs Sales in Volume by Type (2016-2026)
5.2 Global Urological Cancer Therapeutics Drugs Revenue by Type (2016-2026)
5.3 Global Urological Cancer Therapeutics Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Urological Cancer Therapeutics Drugs Sales in Volume by Application (2016-2026)
6.2 Global Urological Cancer Therapeutics Drugs Revenue by Application (2016-2026)
6.3 Global Urological Cancer Therapeutics Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Urological Cancer Therapeutics Drugs Sales by Type (2016-2026)
7.2 North America Urological Cancer Therapeutics Drugs Sales by Application (2016-2026)
7.3 North America Urological Cancer Therapeutics Drugs Market Size by Country
7.3.1 North America Urological Cancer Therapeutics Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Urological Cancer Therapeutics Drugs Sales by Type (2016-2026)
8.2 Europe Urological Cancer Therapeutics Drugs Sales by Application (2016-2026)
8.3 Europe Urological Cancer Therapeutics Drugs Market Size by Country
8.3.1 Europe Urological Cancer Therapeutics Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Urological Cancer Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Urological Cancer Therapeutics Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Urological Cancer Therapeutics Drugs Sales by Type (2016-2026)
10.2 South America Urological Cancer Therapeutics Drugs Sales by Application (2016-2026)
10.3 South America Urological Cancer Therapeutics Drugs Market Size by Country
10.3.1 South America Urological Cancer Therapeutics Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Urological Cancer Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Urological Cancer Therapeutics Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Urological Cancer Therapeutics Drugs Typical Distributors
12.3 Urological Cancer Therapeutics Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Urological Cancer Therapeutics Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Urological Cancer Therapeutics Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Urological Cancer Therapeutics Drugs Product and Services
Table 6. Novartis Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Urological Cancer Therapeutics Drugs Product and Services
Table 10. Pfizer Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Urological Cancer Therapeutics Drugs Product and Services
Table 14. Johnson & Johnson Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Urological Cancer Therapeutics Drugs Product and Services
Table 18. AstraZeneca Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Astellas Basic Information, Manufacturing Base and Competitors
Table 20. Astellas Major Business
Table 21. Astellas Urological Cancer Therapeutics Drugs Product and Services
Table 22. Astellas Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product and Services
Table 26. Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Laboratories Major Business
Table 29. Abbott Laboratories Urological Cancer Therapeutics Drugs Product and Services
Table 30. Abbott Laboratories Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Celgene Corporation Major Business
Table 33. Celgene Corporation Urological Cancer Therapeutics Drugs Product and Services
Table 34. Celgene Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Dendreon Corporation Major Business
Table 37. Dendreon Corporation Urological Cancer Therapeutics Drugs Product and Services
Table 38. Dendreon Corporation Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Ferring Pharmaceuticals Major Business
Table 41. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product and Services
Table 42. Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline plc Major Business
Table 45. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product and Services
Table 46. GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Indevus Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 48. Indevus Pharmaceuticals Inc Major Business
Table 49. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product and Services
Table 50. Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Ipsen Basic Information, Manufacturing Base and Competitors
Table 52. Ipsen Major Business
Table 53. Ipsen Urological Cancer Therapeutics Drugs Product and Services
Table 54. Ipsen Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Roche Healthcare Basic Information, Manufacturing Base and Competitors
Table 56. Roche Healthcare Major Business
Table 57. Roche Healthcare Urological Cancer Therapeutics Drugs Product and Services
Table 58. Roche Healthcare Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 60. Sanofi S.A. Major Business
Table 61. Sanofi S.A. Urological Cancer Therapeutics Drugs Product and Services
Table 62. Sanofi S.A. Urological Cancer Therapeutics Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Urological Cancer Therapeutics Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 64. Global Urological Cancer Therapeutics Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Urological Cancer Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Urological Cancer Therapeutics Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 67. Head Office and Urological Cancer Therapeutics Drugs Production Site of Key Manufacturer
Table 68. Urological Cancer Therapeutics Drugs New Entrant and Capacity Expansion Plans
Table 69. Urological Cancer Therapeutics Drugs Mergers & Acquisitions in the Past Five Years
Table 70. Global Urological Cancer Therapeutics Drugs Sales by Region (2016-2021e) & (K MT)
Table 71. Global Urological Cancer Therapeutics Drugs Sales by Region (2021-2026) & (K MT)
Table 72. Global Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Urological Cancer Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 75. Global Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 76. Global Urological Cancer Therapeutics Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Urological Cancer Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Urological Cancer Therapeutics Drugs Price by Type (2016-2021e) & (USD/MT)
Table 79. Global Urological Cancer Therapeutics Drugs Price by Type (2021-2026) & (USD/MT)
Table 80. Global Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 81. Global Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 82. Global Urological Cancer Therapeutics Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Urological Cancer Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Urological Cancer Therapeutics Drugs Price by Application (2016-2021e) & (USD/MT)
Table 85. Global Urological Cancer Therapeutics Drugs Price by Application (2021-2026) & (USD/MT)
Table 86. North America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021e) & (K MT)
Table 87. North America Urological Cancer Therapeutics Drugs Sales by Country (2021-2026) & (K MT)
Table 88. North America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Urological Cancer Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 91. North America Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 92. North America Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 93. North America Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 94. Europe Urological Cancer Therapeutics Drugs Sales by Country (2016-2021e) & (K MT)
Table 95. Europe Urological Cancer Therapeutics Drugs Sales by Country (2021-2026) & (K MT)
Table 96. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Urological Cancer Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 99. Europe Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 100. Europe Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 101. Europe Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 102. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Region (2016-2021e) & (K MT)
Table 103. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Region (2021-2026) & (K MT)
Table 104. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 107. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 108. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 109. Asia-Pacific Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 110. South America Urological Cancer Therapeutics Drugs Sales by Country (2016-2021e) & (K MT)
Table 111. South America Urological Cancer Therapeutics Drugs Sales by Country (2021-2026) & (K MT)
Table 112. South America Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Urological Cancer Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 115. South America Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 116. South America Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 117. South America Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 118. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Country (2016-2021e) & (K MT)
Table 119. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Country (2021-2026) & (K MT)
Table 120. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Type (2016-2021e) & (K MT)
Table 123. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Type (2021-2026) & (K MT)
Table 124. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Application (2016-2021e) & (K MT)
Table 125. Middle East & Africa Urological Cancer Therapeutics Drugs Sales by Application (2021-2026) & (K MT)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Urological Cancer Therapeutics Drugs Typical Distributors
Table 129. Urological Cancer Therapeutics Drugs Typical Customers
List of Figures
Figure 1. Urological Cancer Therapeutics Drugs Picture
Figure 2. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type in 2020
Figure 3. Xofigo (radium Ra 223 dichloride)
Figure 4. Jevtana (cabazitaxel)
Figure 5. Inlyta (axitinib)
Figure 6. Votrient (pazopanib hydrochloride)
Figure 7. Sutent (sunitinib malate)
Figure 8. Zytiga (abiraterone acetate)
Figure 9. Xtandi (enzalutamide)
Figure 10. Opdivo (nivolumab)
Figure 11. Provenge (sipuleucel-T)
Figure 12. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application in 2020
Figure 13. Hospital
Figure 14. Medical Research Laboratory
Figure 15. Others
Figure 16. Global Urological Cancer Therapeutics Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 17. Global Urological Cancer Therapeutics Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. Global Urological Cancer Therapeutics Drugs Sales (2016-2026) & (K MT)
Figure 19. Global Urological Cancer Therapeutics Drugs Price by Type (2016-2026) & (USD/MT)
Figure 20. Global Urological Cancer Therapeutics Drugs Production Capacity (2016-2026) & (K MT)
Figure 21. Global Urological Cancer Therapeutics Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 22. Urological Cancer Therapeutics Drugs Market Drivers
Figure 23. Urological Cancer Therapeutics Drugs Market Restraints
Figure 24. Urological Cancer Therapeutics Drugs Market Trends
Figure 25. Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturer in 2020
Figure 26. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Manufacturer in 2020
Figure 27. Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. Top 3 Urological Cancer Therapeutics Drugs Manufacturer (Revenue) Market Share in 2020
Figure 29. Top 6 Urological Cancer Therapeutics Drugs Manufacturer (Revenue) Market Share in 2020
Figure 30. Global Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 31. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 32. North America Urological Cancer Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Europe Urological Cancer Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 34. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 35. South America Urological Cancer Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 36. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 37. Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 38. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2016-2026)
Figure 39. Global Urological Cancer Therapeutics Drugs Price by Type (2016-2026) & (USD/MT)
Figure 40. Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 41. Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2016-2026)
Figure 42. Global Urological Cancer Therapeutics Drugs Price by Application (2016-2026) & (USD/MT)
Figure 43. North America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 44. North America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 45. North America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 46. North America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 47. United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 51. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 52. Europe Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 53. Europe Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 54. Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Urological Cancer Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 63. China Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Korea Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 71. South America Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 72. South America Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East & Africa Urological Cancer Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Urological Cancer Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Urological Cancer Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Urological Cancer Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Egypt Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South Africa Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Buy
